We report in this study that p53 is variably expressed in cells from BC CML patient samples, and that MDM2 expression is significantly higher, and p53 expression is lower, in quiescent compared to proliferating CD34+ progenitor cells. The gene discussed is TP53; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.